Literature DB >> 22126916

PlGF knockout delays brain vessel growth and maturation upon systemic hypoxic challenge.

Moises Freitas-Andrade1, Peter Carmeliet, Claudie Charlebois, Danica B Stanimirovic, Maria J Moreno.   

Abstract

In this study, we have investigated the potential role of placental growth factor (PlGF) in hypoxia-induced brain angiogenesis. To this end, PlGF wild-type (PlGF(+/+)) and PlGF knockout (PlGF(-/-)) mice were exposed to whole body hypoxia (10% oxygen) for 7, 14, and 21 days. PlGF(+/+) animals exhibited a significant ~40% increase in angiogenesis after 7 days of hypoxia compared with controls, while in PlGF(-/-) this effect only occurred after 14 days of hypoxia. No differences in pericyte/smooth muscle cell (SMC) coverage between the two genotypes were observed. After 14 days of hypoxia, PlGF(-/-) microvessels had a significant increase in fibrinogen accumulation and extravasation compared with those of PlGF(+/+), which correlated with endothelial cell disruption of the tight junction protein claudin-5. These vessels displayed large lumens, were surrounded by reactive astrocytes, lacked both pericyte/SMC coverage and endothelial vascular endothelial growth factor expression, and regressed after 21 days of hypoxia. Vascular endothelial growth factor expression levels were found to be significantly lower in the frontal cortex of PlGF(-/-) compared with those in PlGF(+/+) animals during the first 5 days of hypoxia, which in combination with the lack of PlGF may have contributed to the delayed angiogenic response and the prothrombotic phenotype observed in the PlGF(-/-)animals.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126916      PMCID: PMC3318143          DOI: 10.1038/jcbfm.2011.167

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

Review 1.  Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.

Authors:  A Ahmed; C Dunk; S Ahmad; A Khaliq
Journal:  Placenta       Date:  2000 Mar-Apr       Impact factor: 3.481

2.  Pericytes regulate the blood-brain barrier.

Authors:  Annika Armulik; Guillem Genové; Maarja Mäe; Maya H Nisancioglu; Elisabet Wallgard; Colin Niaudet; Liqun He; Jenny Norlin; Per Lindblom; Karin Strittmatter; Bengt R Johansson; Christer Betsholtz
Journal:  Nature       Date:  2010-10-13       Impact factor: 49.962

3.  Placental growth factor is a survival factor for tumor endothelial cells and macrophages.

Authors:  Avner Adini; Tad Kornaga; Farshid Firoozbakht; Laura E Benjamin
Journal:  Cancer Res       Date:  2002-05-15       Impact factor: 12.701

4.  Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling.

Authors:  Heike Beck; Till Acker; Andreas W Püschel; Hajime Fujisawa; Peter Carmeliet; Karl H Plate
Journal:  J Neuropathol Exp Neurol       Date:  2002-04       Impact factor: 3.685

5.  Temporal profile of angiogenesis and expression of related genes in the brain after ischemia.

Authors:  Takeshi Hayashi; Nobuo Noshita; Taku Sugawara; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2003-02       Impact factor: 6.200

Review 6.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

Review 7.  Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders.

Authors:  M Autiero; A Luttun; M Tjwa; P Carmeliet
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

8.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Authors:  Aernout Luttun; Marc Tjwa; Lieve Moons; Yan Wu; Anne Angelillo-Scherrer; Fang Liao; Janice A Nagy; Andrea Hooper; Josef Priller; Bert De Klerck; Veerle Compernolle; Evis Daci; Peter Bohlen; Mieke Dewerchin; Jean-Marc Herbert; Roy Fava; Patrick Matthys; Geert Carmeliet; Désiré Collen; Harold F Dvorak; Daniel J Hicklin; Peter Carmeliet
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

9.  Placental growth factor induces FosB and c-Fos gene expression via Flt-1 receptors.

Authors:  David I R Holmes; Ian Zachary
Journal:  FEBS Lett       Date:  2004-01-16       Impact factor: 4.124

10.  Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.

Authors:  Monica Autiero; Johannes Waltenberger; Didier Communi; Andrea Kranz; Lieve Moons; Diether Lambrechts; Jens Kroll; Stephane Plaisance; Maria De Mol; Françoise Bono; Stefanie Kliche; Guido Fellbrich; Kurt Ballmer-Hofer; Domenico Maglione; Ulrike Mayr-Beyrle; Mieke Dewerchin; Saskia Dombrowski; Danica Stanimirovic; Paul Van Hummelen; Christoph Dehio; Daniel J Hicklin; Graziella Persico; Jean-Marc Herbert; David Communi; Masabumi Shibuya; Désiré Collen; Edward M Conway; Peter Carmeliet
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

View more
  17 in total

1.  PLGF-1 contained in normal wound myofibroblast-derived microvesicles stimulated collagen production by dermal fibroblasts.

Authors:  Syrine Arif; Sébastien Larochelle; Véronique J Moulin
Journal:  J Cell Commun Signal       Date:  2020-07-01       Impact factor: 5.782

2.  Chronic cerebral hypoxia promotes arteriogenic remodeling events that can be identified by reduced endoglin (CD105) expression and a switch in β1 integrins.

Authors:  Amin Boroujerdi; Jennifer V Welser-Alves; Ulrich Tigges; Richard Milner
Journal:  J Cereb Blood Flow Metab       Date:  2012-06-27       Impact factor: 6.200

Review 3.  Placental growth factor: What hematologists need to know.

Authors:  Laura F Newell; Shernan G Holtan
Journal:  Blood Rev       Date:  2016-08-27       Impact factor: 8.250

4.  Defining the critical hypoxic threshold that promotes vascular remodeling in the brain.

Authors:  Amin Boroujerdi; Richard Milner
Journal:  Exp Neurol       Date:  2014-10-22       Impact factor: 5.330

Review 5.  Central Role of Metabolism in Endothelial Cell Function and Vascular Disease.

Authors:  Laura Bierhansl; Lena-Christin Conradi; Lucas Treps; Mieke Dewerchin; Peter Carmeliet
Journal:  Physiology (Bethesda)       Date:  2017-03

Review 6.  Vascular endothelial growth factors (VEGFs) and stroke.

Authors:  David A Greenberg; Kunlin Jin
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

Review 7.  The Beneficial Potential of Genetically Modified Stem Cells in the Treatment of Stroke: a Review.

Authors:  Mohammad Saied Salehi; Anahid Safari; Sareh Pandamooz; Benjamin Jurek; Etrat Hooshmandi; Maryam Owjfard; Mahnaz Bayat; Seyedeh Shaghayegh Zafarmand; Jaleel A Miyan; Afshin Borhani-Haghighi
Journal:  Stem Cell Rev Rep       Date:  2021-05-25       Impact factor: 6.692

8.  Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.

Authors:  Kelly J Ledford; Nikki Murphy; Frank Zeigler; Ronnda L Bartel; Ross Tubo
Journal:  Stem Cell Res Ther       Date:  2015-03-13       Impact factor: 6.832

Review 9.  Brain homeostasis: VEGF receptor 1 and 2-two unequal brothers in mind.

Authors:  Ina M Wittko-Schneider; Fabian T Schneider; Karl H Plate
Journal:  Cell Mol Life Sci       Date:  2013-03-12       Impact factor: 9.261

10.  Genetic mouse models to study blood-brain barrier development and function.

Authors:  Fabien Sohet; Richard Daneman
Journal:  Fluids Barriers CNS       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.